Literature DB >> 8587630

Regression of nephrotic syndrome with colchicine therapy secondary to amyloidosis with associated Castleman's disease.

S Paydas, G Gonlusen, Y Sagliker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8587630     DOI： 10.1159/000188770

Source DB:  PubMed          Journal:  Nephron        ISSN： 1660-8151            Impact factor:   2.847


× No keyword cloud information.
  4 in total

Review 1.  Renal complications of Castleman's disease: report of two cases and analysis of 75 cases.

Authors:  Xiang-Gui Yuan; Wen Hu; Fei-Fei Chen; Bin-Feng Huang; Xiao-Ying Zhao
Journal:  Clin Exp Nephrol       Date:  2011-08-06       Impact factor: 2.801

Review 2.  Glucocorticoids in Alzheimer's disease. The story so far.

Authors:  P S Aisen; G M Pasinetti
Journal:  Drugs Aging       Date:  1998-01       Impact factor: 3.923

Review 3.  An autopsy case of multicentric Castleman's disease associated with interstitial nephritis and secondary AA amyloidosis.

Authors:  Yuriko Morita-Hoshi; Shuji Tohda; Osamu Miura; Nobuo Nara
Journal:  Int J Hematol       Date:  2007-12-08       Impact factor: 2.490

Review 4.  AA amyloidosis associated with Castleman disease: A case report and review of the literature.

Authors:  Luca Bernabei; Adam Waxman; Gabriel Caponetti; David C Fajgenbaum; Brendan M Weiss
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.